Heron Therapeutics, Inc.
Heron Therapeutics, Inc. is a biopharmaceutical company focused on developing novel treatments for cancer
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Heron Therapeutics' stock with a target price of $6.75, indicating strong growth potential.
Financial Health
Heron Therapeutics is showing strong revenue and profitability, with positive cash flow per share.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring HRTX
FDA Cancer Warning: Beyond the Treatment Headlines
The FDA's new boxed warning for a major cancer therapy from Johnson & Johnson and Legend Biotech highlights the serious side effects of advanced treatments. This focus creates an investment opportunity in companies that develop drugs and therapies to help manage these adverse reactions, improving patient quality of life.
Published: October 12, 2025
Explore BasketNavigating U.S. Drug Price Reforms
The White House is demanding major pharmaceutical companies slash U.S. drug prices, creating significant market volatility and threatening industry profits. This creates a potential opening for companies that offer cost-saving alternatives, such as generic drug makers and healthcare service providers.
Published: August 5, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Clinical Catalyst Watch
Upcoming clinical readouts and regulatory milestones can move the share price; positive data may lift sentiment, though trial outcomes are uncertain.
Commercial & Partnerships
Revenue often depends on product uptake and licensing deals; partnerships can broaden reach but terms and milestone risks vary.
Small‑cap Volatility
With a market cap near $238M, liquidity can be limited and price swings larger than for bigger peers; consider diversification and risk tolerance.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals develops treatments for diseases including cystic fibrosis and cancer.
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals is a leading biotechnology company that develops and manufactures innovative medicines for serious medical conditions.
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics based on RNA interference (RNAi).
